Eyepoint Pharmaceuticals Inc

Stock Chart, Company Information, and Scan Results

$17.37(as of Jan 7, 3:59 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Eyepoint Pharmaceuticals Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$17.37
Ticker SymbolEYPT
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees165
CountyUSA
Market Cap$1,443.0M
EBIDTA-216.3M
10-Day Moving Average17.99
P/E Ratio-5.75
20-Day Moving Average17.41
Forward P/E Ratio0.00
50-Day Moving Average14.84
Earnings per Share-3.00
200-Day Moving Average10.83
Profit Margin-6,183.44%
RSI51.33
Shares Outstanding82.8M
ATR0.96
52-Week High19.11
Volume737,566
52-Week Low3.91
Most Recent Support Level16.67
Book Value200.2M
Most Recent Resistance Level18.50
P/B Ratio5.91
Upper Keltner19.57
P/S Ratio27.94
Lower Keltner15.24
Debt-to-Equity Ratio19.57
Next Earnings Date03/05/2026
Cash Surplus44.5M
Next Ex-Dividend DateUnknown

EyePoint, Inc. engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases. The company's pipeline leverages its proprietary bioerodible Durasert E technology for sustained intraocular drug delivery. Its lead product candidate is DURAVYU, an investigational sustained delivery treatment for VEGF-mediated retinal diseases combining vorolanib, a selective and patent-protected tyrosine kinase inhibitor with Durasert E which is in Phase 3 clinical trials for wet age-related macular degeneration (wet AMD), non-proliferative diabetic retinopathy (NPDR), and diabetic macular edema (DME). The company's pipeline programs also include EYP-2301, a promising TIE-2 agonist formulated in Durasert E that is in pre-clinical development phase for potentially improve outcomes in serious retinal diseases. The company was formerly known as EyePoint Pharmaceuticals, Inc. and changed its name to EyePoint, Inc. in December 2025. EyePoint, Inc. was incorporated in 1987 and is headquartered in Watertown, Massachusetts.

Eyepoint Pharmaceuticals Inc In Our Stock Scanner

As of Jan 07, 2026
example chart graphic
Scan Name: Undervalued Blue ChipsScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Undervalued StocksScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.